Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
21 November 2023 - 3:45AM
Update on the receivership proceedings:
submission of a takeover offer to the court-appointed
administrators
Paris, France, November 20,
2023 – 5:45 pm
(CET) – Pixium Vision SA (Euronext Growth Paris -
FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing
innovative vision systems to enable patients who have lost their
sight to live more independent lives, whose safeguard proceedings
(procédure de sauvegarde) were converted into receivership
(redressement judiciaire) by decision of the Paris Commercial Court
on November 13, 2023, announces that the court-appointed
administrators have today received a takeover offer for the assets
and activities of Pixium.
The date for the hearing to examine the takeover
offer will be set by the Commercial Court by the end of
November.
The Company draws investors’ attention to the
fact that, given the current offer and the Company’s level of
indebtedness, the sale proceeds received in the context of the
Company’s insolvency proceedings do not allow a total or partial
reimbursement of shareholders.
About Pixium Vision
Pixium Vision is creating a
world of bionic vision for those who have lost their sight,
enabling them to regain visual perception and greater autonomy.
Pixium Vision’s bionic vision systems are associated with a
surgical intervention and a rehabilitation period. Prima System
sub-retinal miniature photovoltaic wireless implant is in clinical
testing for patients who have lost their sight due to outer retinal
degeneration, initially for atrophic dry age-related macular
degeneration (dry AMD). Pixium Vision collaborates closely with
academic and research partners, including some of the most
prestigious vision research institutions in the world, such as
Stanford University in California, Institut de la Vision in Paris,
Moorfields Eye Hospital in London, Institute of Ocular Microsurgery
(IMO) in Barcelona, University hospital in Bonn, and UPMC in
Pittsburgh, PA. The Company is EN ISO 13485 certified and qualifies
as “Entreprise Innovante” by Bpifrance.
For more information:
http://www.pixium-vision.com/fr
Follow us on @PixiumVision;
www.facebook.com/pixiumvision
www.linkedin.com/company/pixium-vision
Contacts
Investor
RelationsPixium VisionOffer NonhoffChief
Financial Officerinvestors@pixium-vision.com |
Media
Relations Rose Piquante ConsultingSophie
BaumontSophie.baumont@rosepiquante-consulting.com+33 6 27 74 74
49 |
- Pixium - PR update on the receivership (offer received) -
20.11.2023
Pixium Vision (EU:ALPIX)
Historical Stock Chart
From Apr 2024 to May 2024
Pixium Vision (EU:ALPIX)
Historical Stock Chart
From May 2023 to May 2024